Ehab L Atallah: Clinical Trials

4 trials sponsored by Ehab L Atallah, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed, 1 withdrawn. 3 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Terminated 2, Withdrawn 1
Phase 21Completed 1

Follow Ehab L Atallah: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
XmAb18968 (CD3-CD38) in Relapsed or Refractory Acute Leukemia and T Cell Lymphoblastic Leukemia
XmAb18968 - Dose level -1, XmAb18968 - Dose level 0 (starting dose), XmAb18968 - Dose level 1 - Acute Myeloid Leukemia, T Cell Acute Lymphoblastic Leukemia
Phase 1TerminatedEhab L Atallah222022-02-022025-05-08
Standard Maintenance POMP/D Plus Ixazomib Maintenance Therapy in Adult Patients With Acute Lymphoblastic Leukemia, Lymphoblastic Lymphoma or Mixed Phenotype Acute Leukemia in Complete Remission (CR)
Ixazomib - Acute Lymphoblastic Leukemia in Complete Remission, Lymphoblastic Lymphoma in Complete Remission
Phase 1WithdrawnEhab L Atallah2017-06-292018-02-15
Hypomethylating Properties of Freeze-dried Black Raspberries (BRB) in Patients With Myelodysplastic Syndrome or Myelodysplastic Syndrome/Myeloproliferative Neoplasm (MDS/MPN)
Freeze-Dried Black Raspberry Powder - Myelodysplastic Syndromes
Phase 2CompletedEhab L Atallah232017-06-052022-11-04
Vincristine, Doxorubicin, And Dexamethasone + Ixazomib in Acute Lymphoblastic Leukemia (ALL), Lymphoblastic Lymphoma Or Mixed Phenotype Acute Leukemia
MLN9708, Vincristine, Doxorubicin - Relapsed or Refractory Acute Lymphoblastic Leukemia, Relapsed or Refractory Lymphoblastic Lymphoma
Phase 1TerminatedEhab L Atallah52013-06-012020-01-22

Conditions studied

Leukemia, Biphenotypic, Acute (2)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (2)  ·  Leukemia, Myeloid, Acute (1)  ·  Myelodysplastic Syndromes (1)  ·  Precursor T-Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Recurrence (1)

Interventions

ixazomib (2)  ·  Calcium Dobesilate (1)  ·  Dexamethasone (1)  ·  Doxorubicin (1)  ·  Vincristine (1)  ·  liposomal doxorubicin (1)

Countries

United States (4)

Top investigators

Ehab Atallah, MD (3)

Results publications

PMID 42736326